Hannah Park • UCI Profiles (original) (raw)

  1. WISDOM Randomized Trial Comparing Risk-Based Versus Annual Breast Cancer Screening: Study Cohort Characteristics and Design. Res Sq. 2025 Dec 15. Fiscalini A, Blum K, Fergus K, Hiatt RA, Naeim A, Kaster A, Scheuner MT, van 't Veer LJ, LaCroix AZ, Borowsky AD, Olopade OI, Park HL, Esserman J, Lancaster R, Heditsian D, Brain S, Lee V, Goodman DL, Ross KS, Wenger N, Parker BA, Madlensky L, Tice JA, Shieh Y, Ziv E, Arasu VA, Anton-Culver H, Kaplan CP, Rhoads KF, Badal K, Hogarth M, Petruse A, Soto IA, Leggat-Barr K, Goodman S, Atamer J, Ryu R, Adduci K, Matthews JB, Eklund M, Athena/WISDOM Network Collaborators and Advocate Partners, Sabacan LP, Esserman L. PMID: 41255969; PMCID: PMC12622172.
    View in: PubMed Mentions:
  2. Hormone therapy use and young-onset breast cancer: a pooled analysis of prospective cohorts included in the Premenopausal Breast Cancer Collaborative Group. Lancet Oncol. 2025 Jul; 26(7):911-923. O'Brien KM, House MG, Goldberg M, Jones ME, Weinberg CR, de Gonzalez AB, Bertrand KA, Blot WJ, DeHart JC, Couch FJ, Garcia-Closas M, Giles GG, Kirsh VA, Kitahara CM, Koh WP, Park HL, Milne RL, Palmer JR, Patel AV, Rohan TE, Schoemaker MJ, Swerdlow AJ, Teras LR, Vachon C, Visvanathan K, Yuan JM, Zheng W, Nichols HB, Sandler DP. PMID: 40609572; PMCID: PMC12233149.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  3. Automated self-service cohort selection for large-scale population sciences and observational research: The California teachers study researcher platform. PLoS One. 2025; 20(5):e0296611. Lacey JV, Spielfogel ES, Benbow JL, Savage KE, Lin K, Anderson CAM, Clague-DeHart J, Duffy CN, Martinez ME, Park HL, Thompson CA, Wang SS, Chandra S. PMID: 40354347; PMCID: PMC12068635.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  4. ALDH2 Deficiency and Alcohol Intake in the United States: Opportunity for Precision Cancer Prevention. Cancer Epidemiol Biomarkers Prev. 2025 May 02; 34(5):744-753. Forman D, Yang M, Chien R, Nguyen H, Wong C, Kim JHJ, Ziogas A, Park HL. PMID: 40063522; PMCID: PMC12048207.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  5. Development and validation of a risk prediction model for premenopausal breast cancer in 19 cohorts. Breast Cancer Res. 2025 May 01; 27(1):67. Brantley KD, Jones ME, Tamimi RM, Rosner BA, Kraft P, Nichols HB, O'Brien KM, Adami HO, Aizpurua A, Berrington de González A, Blot WJ, Braaten T, Chen Y, DeHart JC, Dossus L, Elias S, Fortner RT, Garcia-Closas M, Gram IT, Håkansson N, Hankinson SE, Kitahara CM, Koh WP, Linet MS, MacInnis RJ, Masala G, Mellemkjær L, Milne RL, Muller DC, Park HL, Ruddy KJ, Sandin S, Shu XO, Tin Tin S, Truong T, Vachon CM, Vatten LJ, Visvanathan K, Weiderpass E, Willett W, Wolk A, Yuan JM, Zheng W, Sandler DP, Schoemaker MJ, Swerdlow AJ, Eliassen AH. PMID: 40312753; PMCID: PMC12046669.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  6. Central and peripheral adiposity and premenopausal breast cancer risk: a pooled analysis of 440,179 women. Breast Cancer Res. 2025 Apr 15; 27(1):55. Schoemaker MJ, Ellington T, Nichols HB, Wright LB, Jones ME, O'Brien KM, Weinberg CR, Adami HO, Baglietto L, Bertrand KA, Chen Y, Clague DeHart J, Eliassen AH, Giles GG, Houghton SC, Kirsh VA, Milne RL, Palmer JR, Park HL, Rohan TE, Severi G, Shu XO, Tamimi RM, Vatten LJ, Weiderpass E, Willett WC, Zeleniuch-Jacquotte A, Zheng W, Sandler DP, Swerdlow AJ, Premenopausal Breast Cancer Collaborative Group. PMID: 40234955; PMCID: PMC12001638.
    View in: PubMed Mentions: 3 Fields:
    Translation:Humans
  7. Cell type-specific 3D-genome organization and transcription regulation in the brain. Sci Adv. 2025 Feb 28; 11(9):eadv2067. Liu S, Wang CY, Zheng P, Jia BB, Zemke NR, Ren P, Park HL, Ren B, Zhuang X. PMID: 40009678; PMCID: PMC11864200.
    View in: PubMed Mentions: 6 Fields:
    Translation:AnimalsCells
  8. Potential Role of Glyphosate, Glyphosate-Based Herbicides, and AMPA in Breast Cancer Development: A Review of Human and Human Cell-Based Studies. Int J Environ Res Public Health. 2024 Aug 17; 21(8). Schluter HM, Bariami H, Park HL. PMID: 39200696; PMCID: PMC11354939.
    View in: PubMed Mentions: 3 Fields:
    Translation:Humans
  9. BMI and breast cancer risk around age at menopause. Cancer Epidemiol. 2024 Apr; 89:102545. Von Holle A, Adami HO, Baglietto L, Berrington de Gonzalez A, Bertrand KA, Blot W, Chen Y, DeHart JC, Dossus L, Eliassen AH, Fournier A, Garcia-Closas M, Giles G, Guevara M, Hankinson SE, Heath A, Jones ME, Joshu CE, Kaaks R, Kirsh VA, Kitahara CM, Koh WP, Linet MS, Park HL, Masala G, Mellemkjaer L, Milne RL, O'Brien KM, Palmer JR, Riboli E, Rohan TE, Shrubsole MJ, Sund M, Tamimi R, Tin Tin S, Visvanathan K, Vermeulen RC, Weiderpass E, Willett WC, Yuan JM, Zeleniuch-Jacquotte A, Nichols HB, Sandler DP, Swerdlow AJ, Schoemaker MJ, Weinberg CR. PMID: 38377945; PMCID: PMC10942753.
    View in: PubMed Mentions: 5 Fields:
    Translation:Humans
  10. International Pooled Analysis of Leisure-Time Physical Activity and Premenopausal Breast Cancer in Women From 19 Cohorts. J Clin Oncol. 2024 Mar 10; 42(8):927-939. Timmins IR, Jones ME, O'Brien KM, Adami HO, Aune D, Baglietto L, Bertrand KA, Brantley KD, Chen Y, Clague DeHart J, Clendenen TV, Dossus L, Eliassen AH, Fletcher O, Fournier A, Håkansson N, Hankinson SE, Houlston RS, Joshu CE, Kirsh VA, Kitahara CM, Koh WP, Linet MS, Park HL, Lynch BM, May AM, Mellemkjær L, Milne RL, Palmer JR, Ricceri F, Rohan TE, Ruddy KJ, Sánchez MJ, Shu XO, Smith-Byrne K, Steindorf K, Sund M, Vachon CM, Vatten LJ, Visvanathan K, Weiderpass E, Willett WC, Wolk A, Yuan JM, Zheng W, Nichols HB, Sandler DP, Swerdlow AJ, Schoemaker MJ. PMID: 38079601; PMCID: PMC10927335.
    View in: PubMed Mentions: 7 Fields:
    Translation:Humans
  11. Factors Associated with Longitudinal Changes in Mammographic Density in a Multiethnic Breast Screening Cohort of Postmenopausal Women. Breast J. 2023; 2023:2794603. Park HL, Ziogas A, Feig SA, Kirmizi RL, Lee CJ, Alvarez A, Lucia RM, Goodman D, Larsen KM, Kelly R, Anton-Culver H. PMID: 37881237; PMCID: PMC10597735.
    View in: PubMed Mentions: 1 Fields:
    Translation:Humans
  12. Early Ascertainment of Breast Cancer Diagnoses Comparing Self-Reported Questionnaires and Electronic Health Record Data Warehouse: The WISDOM Study. JCO Clin Cancer Inform. 2023 08; 7:e2300019. Leggat-Barr K, Ryu R, Hogarth M, Stover-Fiscalini A, Veer LV', Park HL, Lewis T, Thompson C, Borowsky A, Hiatt RA, LaCroix A, Parker B, Madlensky L, Naeim A, Esserman L. PMID: 37607323; PMCID: PMC12930483.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  13. Urinary glyphosate and AMPA levels in a cross-sectional study of postmenopausal women: Associations with organic eating behavior and dietary intake. Int J Hyg Environ Health. 2023 07; 252:114211. Lucia RM, Liao X, Huang WL, Forman D, Kim A, Ziogas A, Norden-Krichmar TM, Goodman D, Alvarez A, Masunaka I, Pathak KV, McGilvrey M, Hegde AM, Pirrotte P, Park HL. PMID: 37393842; PMCID: PMC10503538.
    View in: PubMed Mentions: 4 Fields:
    Translation:HumansAnimals
  14. Association of Glyphosate Exposure with Blood DNA Methylation in a Cross-Sectional Study of Postmenopausal Women. Environ Health Perspect. 2022 04; 130(4):47001. Lucia RM, Huang WL, Pathak KV, McGilvrey M, David-Dirgo V, Alvarez A, Goodman D, Masunaka I, Odegaard AO, Ziogas A, Pirrotte P, Norden-Krichmar TM, Park HL. PMID: 35377194; PMCID: PMC8978648.
    View in: PubMed Mentions: 9 Fields:
    Translation:HumansCells
  15. Mammography screening and mortality by risk status in the California teachers study. BMC Cancer. 2021 Dec 18; 21(1):1341. Park HL, Chang J, Haridass V, Wang SS, Ziogas A, Anton-Culver H. PMID: 34922473; PMCID: PMC8684058.
    View in: PubMed Mentions: 5 Fields:
    Translation:Humans
  16. Association of mammographic density with blood DNA methylation. Epigenetics. 2022 05; 17(5):531-546. Lucia RM, Huang WL, Alvarez A, Masunaka I, Ziogas A, Goodman D, Odegaard AO, Norden-Krichmar TM, Park HL. PMID: 34116608; PMCID: PMC9067527.
    View in: PubMed Mentions: 2 Fields:
    Translation:HumansCells
  17. Factors Associated with Women's Unwillingness to Decrease Alcohol Intake to Decrease Breast Cancer Risk. J Prim Care Community Health. 2021 Jan-Dec; 12:21501327211000211. Matin J, Lucia RM, Lal K, Columbus A, Goodman D, Larsen K, Ziogas A, Park HL. PMID: 33749348; PMCID: PMC7983428.
    View in: PubMed Mentions: 2 Fields:
    Translation:Humans
  18. Breast Cancer Risk Prediction in Korean Women: Review and Perspectives on Personalized Breast Cancer Screening. J Breast Cancer. 2020 08; 23(4):331-342. Kim DY, Park HL. PMID: 32908785; PMCID: PMC7462811.
    View in: PubMed Mentions: 5
  19. Organophosphate Pesticide Exposure and Breast Cancer Risk: A Rapid Review of Human, Animal, and Cell-Based Studies. Int J Environ Res Public Health. 2020 07 13; 17(14). Yang KJ, Lee J, Park HL. PMID: 32668751; PMCID: PMC7399930.
    View in: PubMed Mentions: 15 Fields:
    Translation:HumansAnimals
  20. Rationale, Study Design, and Cohort Characteristics for the Markers for Environmental Exposures (MEE) Study. Int J Environ Res Public Health. 2020 03 09; 17(5). Lucia RM, Huang WL, Alvarez A, Thampy D, Elyasian M, Hidajat A, Yang K, Forman D, Pebdani A, Masunaka I, Brain S, Heditsian D, Lee V, Goodman D, Norden-Krichmar TM, Odegaard AO, Ziogas A, Park HL. PMID: 32182891; PMCID: PMC7084413.
    View in: PubMed Mentions: 3 Fields:
    Translation:HumansPHPublic Health
  21. A treatment-based algorithm for identification of diabetes type in the National Health and Nutrition Examination Survey. Cardiovasc Endocrinol Metab. 2020 Mar; 9(1):9-16. Mosslemi M, Park HL, McLaren CE, Wong ND. PMID: 32104786; PMCID: PMC7041875.
    View in: PubMed Mentions: 8
  22. Epigenetic Biomarkers for Environmental Exposures and Personalized Breast Cancer Prevention. Int J Environ Res Public Health. 2020 02 13; 17(4). Park HL. PMID: 32069786; PMCID: PMC7068429.
    View in: PubMed Mentions: 12 Fields:
    Translation:HumansCellsPHPublic Health
  23. Effective risk communication to promote behavioral change in patients at elevated risk for breast cancer based on the Health Belief Model. Breast J. 2018 11; 24(6):1097-1098. Yang M, Barker K, Goodman D, Park HL. PMID: 30079616.
    View in: PubMed Mentions: 1 Fields:
    Translation:Humans
  24. Trends in Treatment Patterns and Clinical Outcomes in Young Women Diagnosed With Ductal Carcinoma In Situ. Clin Breast Cancer. 2018 04; 18(2):e179-e185. Park HL, Chang J, Lal G, Lal K, Ziogas A, Anton-Culver H. PMID: 28941977; PMCID: PMC7817367.
    View in: PubMed Mentions: 13 Fields:
    Translation:Humans
  25. Recreational physical activity and risk of triple negative breast cancer in the California Teachers Study. Breast Cancer Res. 2016 06 17; 18(1):62. Ma H, Xu X, Clague J, Lu Y, Togawa K, Wang SS, Clarke CA, Lee E, Park HL, Sullivan-Halley J, Neuhausen SL, Bernstein L. PMID: 27317095; PMCID: PMC4912767.
    View in: PubMed Mentions: 14 Fields:
    Translation:HumansPHPublic Health
  26. Novel polymorphisms in caspase-8 are associated with breast cancer risk in the California Teachers Study. BMC Cancer. 2016 Jan 12; 16:14. Park HL, Ziogas A, Chang J, Desai B, Bessonova L, Garner C, Lee E, Neuhausen SL, Wang SS, Ma H, Clague J, Reynolds P, Lacey JV, Bernstein L, Anton-Culver H. PMID: 26758508; PMCID: PMC4711015.
    View in: PubMed Mentions: 10 Fields:
    Translation:Humans
  27. Clinical Implementation of a Breast Cancer Risk Assessment Program in a Multiethnic Patient Population: Which Risk Model to Use? Breast J. 2015 Sep-Oct; 21(5):562-4. Park HL, Tran SM, Lee J, Goodman D, Ziogas A, Kelly R, Larsen KM, Alvarez A, Tannous C, Strope J, Lynch W, Anton-Culver H. PMID: 26227105.
    View in: PubMed Mentions: 4 Fields:
    Translation:Humans
  28. Construct validation of the dietary inflammatory index among postmenopausal women. Ann Epidemiol. 2015 Jun; 25(6):398-405. Tabung FK, Steck SE, Zhang J, Ma Y, Liese AD, Agalliu I, Hingle M, Hou L, Hurley TG, Jiao L, Martin LW, Millen AE, Park HL, Rosal MC, Shikany JM, Shivappa N, Ockene JK, Hebert JR. PMID: 25900255; PMCID: PMC4433562.
    View in: PubMed Mentions: 230 Fields:
    Translation:Humans
  29. Human Nail Clippings as a Source of DNA for Genetic Studies. Open J Epidemiol. 2015 Feb 01; 5(1):41-50. Truong L, Park HL, Chang SS, Ziogas A, Neuhausen SL, Wang SS, Bernstein L, Anton-Culver H. PMID: 26180661; PMCID: PMC4499506.
    View in: PubMed Mentions: 5
  30. Self-recalled Youth Physical Activity and Postmenopausal Cardiovascular Disease. Health Behav Policy Rev. 2014 Nov; 1(6):472-483. Goodman D, Park HL, Stefanick M, Hingle M, Lamonte M, LeBlanc E, Johnson K, Desai M, Anton-Culver H. PMID: 26523282; PMCID: PMC4627784.
    View in: PubMed Mentions: 1
  31. Risk of cardiovascular disease among postmenopausal women with prior pregnancy loss: the women's health initiative. Ann Fam Med. 2014 Jul; 12(4):302-9. Parker DR, Lu B, Sands-Lincoln M, Kroenke CH, Lee CC, O'Sullivan M, Park HL, Parikh N, Schenken RS, Eaton CB. PMID: 25024237; PMCID: PMC4096466.
    View in: PubMed Mentions: 34 Fields:
    Translation:Humans
  32. Evaluation of ultra-deep targeted sequencing for personalized breast cancer care. Breast Cancer Res. 2013 Dec 10; 15(6):R115. Harismendy O, Schwab RB, Alakus H, Yost SE, Matsui H, Hasteh F, Wallace AM, Park HL, Madlensky L, Parker B, Carpenter PM, Jepsen K, Anton-Culver H, Frazer KA. PMID: 24326041; PMCID: PMC3978701.
    View in: PubMed Mentions: 11 Fields:
    Translation:Humans
  33. Relation between self-recalled childhood physical activity and adult physical activity: The women's health initiative. Open J Epidemiol. 2013 Nov 01; 3(4):224-231. Goodman D, Park HL, Stefanick M, LeBlanc E, Bea J, Qi L, Kapphahn K, Lamonte M, Manini T, Desai M, Anton-Culver H. PMID: 26877895; PMCID: PMC4749265.
    View in: PubMed Mentions: 2
  34. Prospective analysis of association between statin use and breast cancer risk in the women's health initiative. Cancer Epidemiol Biomarkers Prev. 2013 Oct; 22(10):1868-76. Desai P, Chlebowski R, Cauley JA, Manson JE, Wu C, Martin LW, Jay A, Bock C, Cote M, Petrucelli N, Rosenberg CA, Peters U, Agalliu I, Budrys N, Abdul-Hussein M, Lane D, Luo J, Park HL, Thomas F, Wactawski-Wende J, Simon MS. PMID: 23975947; PMCID: PMC3889164.
    View in: PubMed Mentions: 28 Fields:
    Translation:Humans
  35. Cysteine dioxygenase 1 is a tumor suppressor gene silenced by promoter methylation in multiple human cancers. PLoS One. 2012; 7(9):e44951. Brait M, Ling S, Nagpal JK, Chang X, Park HL, Lee J, Okamura J, Yamashita K, Sidransky D, Kim MS. PMID: 23028699; PMCID: PMC3459978.
    View in: PubMed Mentions: 76 Fields:
    Translation:HumansAnimalsCells
  36. Effects of a dietary intervention and weight change on vasomotor symptoms in the Women's Health Initiative. Menopause. 2012 Sep; 19(9):980-8. Kroenke CH, Caan BJ, Stefanick ML, Anderson G, Brzyski R, Johnson KC, LeBlanc E, Lee C, La Croix AZ, Park HL, Sims ST, Vitolins M, Wallace R. PMID: 22781782; PMCID: PMC3428489.
    View in: PubMed Mentions: 23 Fields:
    Translation:HumansAnimals
  37. Angiogenic factor signaling regulates centrosome duplication in endothelial cells of developing blood vessels. Blood. 2010 Oct 21; 116(16):3108-17. Taylor SM, Nevis KR, Park HL, Rogers GC, Rogers SL, Cook JG, Bautch VL. PMID: 20664058; PMCID: PMC2974614.
    View in: PubMed Mentions: 32 Fields:
    Translation:HumansAnimalsCells
  38. Promoter DNA methylation of oncostatin m receptor-beta as a novel diagnostic and therapeutic marker in colon cancer. PLoS One. 2009 Aug 07; 4(8):e6555. Kim MS, Louwagie J, Carvalho B, Terhaar Sive Droste JS, Park HL, Chae YK, Yamashita K, Liu J, Ostrow KL, Ling S, Guerrero-Preston R, Demokan S, Yalniz Z, Dalay N, Meijer GA, Van Criekinge W, Sidransky D. PMID: 19662090; PMCID: PMC2717211.
    View in: PubMed Mentions: 46 Fields:
    Translation:HumansCells
  39. Pharmacologic unmasking of epigenetically silenced genes in breast cancer. Clin Cancer Res. 2009 Feb 15; 15(4):1184-91. Ostrow KL, Park HL, Hoque MO, Kim MS, Liu J, Argani P, Westra W, Van Criekinge W, Sidransky D. PMID: 19228724; PMCID: PMC3082476.
    View in: PubMed Mentions: 38 Fields:
    Translation:HumansCells
  40. The role of PGP9.5 as a tumor suppressor gene in human cancer. Int J Cancer. 2008 Aug 15; 123(4):753-9. Tokumaru Y, Yamashita K, Kim MS, Park HL, Osada M, Mori M, Sidransky D. PMID: 18512240; PMCID: PMC3069849.
    View in: PubMed Mentions: 33 Fields:
    Translation:HumansCells
  41. DCC promoter hypermethylation in esophageal squamous cell carcinoma. Int J Cancer. 2008 Jun 01; 122(11):2498-502. Park HL, Kim MS, Yamashita K, Westra W, Carvalho AL, Lee J, Jiang WW, Baek JH, Liu J, Osada M, Moon CS, Califano JA, Mori M, Sidransky D. PMID: 18302152.
    View in: PubMed Mentions: 27 Fields:
    Translation:HumansCells
  42. Genome-wide promoter analysis uncovers portions of the cancer methylome. Cancer Res. 2008 Apr 15; 68(8):2661-70. Hoque MO, Kim MS, Ostrow KL, Liu J, Wisman GB, Park HL, Poeta ML, Jeronimo C, Henrique R, Lendvai A, Schuuring E, Begum S, Rosenbaum E, Ongenaert M, Yamashita K, Califano J, Westra W, van der Zee AG, Van Criekinge W, Sidransky D. PMID: 18413733; PMCID: PMC3102297.
    View in: PubMed Mentions: 80 Fields:
    Translation:HumansCells
  43. HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma. Mol Cancer Res. 2008 Jan; 6(1):31-41. Yamashita K, Kim MS, Park HL, Tokumaru Y, Osada M, Inoue H, Mori M, Sidransky D. PMID: 18234960.
    View in: PubMed Mentions: 30 Fields:
    Translation:HumansCells
  44. Alterations of GPI transamidase subunits in head and neck squamous carcinoma. Mol Cancer. 2007 Nov 21; 6:74. Jiang WW, Zahurak M, Zhou ZT, Park HL, Guo ZM, Wu GJ, Sidransky D, Trink B, Califano JA. PMID: 18028549; PMCID: PMC2204038.
    View in: PubMed Mentions: 12 Fields:
    Translation:HumansCells
  45. A promoter methylation pattern in the N-methyl-D-aspartate receptor 2B gene predicts poor prognosis in esophageal squamous cell carcinoma. Clin Cancer Res. 2007 Nov 15; 13(22 Pt 1):6658-65. Kim MS, Yamashita K, Chae YK, Tokumaru Y, Chang X, Zahurak M, Osada M, Park HL, Chuang A, Califano JA, Sidransky D. PMID: 18006766.
    View in: PubMed Mentions: 12 Fields:
    Translation:HumansCells
  46. Quantitative hypermethylation of NMDAR2B in human gastric cancer. Int J Cancer. 2007 Nov 01; 121(9):1994-2000. Liu JW, Kim MS, Nagpal J, Yamashita K, Poeta L, Chang X, Lee J, Park HL, Jeronimo C, Westra WH, Mori M, Moon C, Trink B, Sidransky D. PMID: 17620329.
    View in: PubMed Mentions: 33 Fields:
    Translation:HumansCells
  47. A p53-type response element in the GDF15 promoter confers high specificity for p53 activation. Biochem Biophys Res Commun. 2007 Mar 23; 354(4):913-8. Osada M, Park HL, Park MJ, Liu JW, Wu G, Trink B, Sidransky D. PMID: 17276395; PMCID: PMC1975780.
    View in: PubMed Mentions: 48 Fields:
    Translation:HumansCells
  48. Increased plasma DNA integrity index in head and neck cancer patients. Int J Cancer. 2006 Dec 01; 119(11):2673-6. Jiang WW, Zahurak M, Goldenberg D, Milman Y, Park HL, Westra WH, Koch W, Sidransky D, Califano J. PMID: 16991120.
    View in: PubMed Mentions: 32 Fields:
    Translation:HumansCells
  49. Deleted in colorectal cancer is a putative conditional tumor-suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinoma. Cancer Res. 2006 Oct 01; 66(19):9401-7. Carvalho AL, Chuang A, Jiang WW, Lee J, Begum S, Poeta L, Zhao M, Jerónimo C, Henrique R, Nayak CS, Park HL, Brait MR, Liu C, Zhou S, Koch W, Fazio VM, Ratovitski E, Trink B, Westra W, Sidransky D, Moon CS, Califano JA. PMID: 17018594.
    View in: PubMed Mentions: 35 Fields:
    Translation:HumansCells
  50. N-methyl-D-aspartate receptor type 2B is epigenetically inactivated and exhibits tumor-suppressive activity in human esophageal cancer. Cancer Res. 2006 Apr 01; 66(7):3409-18. Kim MS, Yamashita K, Baek JH, Park HL, Carvalho AL, Osada M, Hoque MO, Upadhyay S, Mori M, Moon C, Sidransky D. PMID: 16585162.
    View in: PubMed Mentions: 53 Fields:
    Translation:HumansCells
  51. PGP9.5 methylation in diffuse-type gastric cancer. Cancer Res. 2006 Apr 01; 66(7):3921-7. Yamashita K, Park HL, Kim MS, Osada M, Tokumaru Y, Inoue H, Mori M, Sidransky D. PMID: 16585221.
    View in: PubMed Mentions: 39 Fields:
    Translation:HumansCells
  52. A novel response element confers p63- and p73-specific activation of the WNT4 promoter. Biochem Biophys Res Commun. 2006 Jan 27; 339(4):1120-8. Osada M, Park HL, Nagakawa Y, Begum S, Yamashita K, Wu G, Kim MS, Trink B, Sidransky D. PMID: 16343436.
    View in: PubMed Mentions: 17 Fields:
    Translation:HumansCells
  53. p63-specific activation of the BPAG-1e promoter. J Invest Dermatol. 2005 Jul; 125(1):52-60. Osada M, Nagakawa Y, Park HL, Yamashita K, Wu G, Kim MS, Fomenkov A, Trink B, Sidransky D. PMID: 15982302.
    View in: PubMed Mentions: 18 Fields:
    Translation:AnimalsCells
  54. Differential recognition of response elements determines target gene specificity for p53 and p63. Mol Cell Biol. 2005 Jul; 25(14):6077-89. Osada M, Park HL, Nagakawa Y, Yamashita K, Fomenkov A, Kim MS, Wu G, Nomoto S, Trink B, Sidransky D. PMID: 15988020; PMCID: PMC1168821.
    View in: PubMed Mentions: 65 Fields:
    Translation:HumansAnimalsCells
  55. PGP9.5 promoter methylation is an independent prognostic factor for esophageal squamous cell carcinoma. Cancer Res. 2005 Jun 01; 65(11):4963-8. Mandelker DL, Yamashita K, Tokumaru Y, Mimori K, Howard DL, Tanaka Y, Carvalho AL, Jiang WW, Park HL, Kim MS, Osada M, Mori M, Sidransky D. PMID: 15930319.
    View in: PubMed Mentions: 60 Fields:
    Translation:HumansCells
  56. Altered sumoylation of p63alpha contributes to the split-hand/foot malformation phenotype. Cell Cycle. 2004 Dec; 3(12):1587-96. Huang YP, Wu G, Guo Z, Osada M, Fomenkov T, Park HL, Trink B, Sidransky D, Fomenkov A, Ratovitski EA. PMID: 15539951.
    View in: PubMed Mentions: 26 Fields:
    Translation:HumansAnimalsCells

Start with: newest oldestInclude: line numbers double spacing all authors publication IDs